MiniMed Group, Inc. stock forecast
Want to see MMED full AI Analyst Report?
MiniMed Group, Inc. (MMED) Stock Forecast & Price Target
MMED Analyst Ratings
MMED Stock 12 Month Forecast
Average Price Target
$26.00▲(44.52% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Christopher Pasquale | Barclays | $22→$20 | hold | 11.17%Upside | Reiterated | 11/13/26 | ||
| Joanne Wuensch | Citi | $26 | buy | 44.52%Upside | Reiterated | 10/21/26 | ||
| Issie Kirby | Rothschild & Co Redburn | $30 | buy | 66.76%Upside | Initiated | 10/13/26 | ||
| Michael Toomey | Jefferies | $22 | hold | 22.29%Upside | Initiated | 10/12/26 | ||
| Marie Thibault | BTIG | $28 | buy | 55.64%Upside | Reiterated | 10/09/26 | ||
| Anthony Petrone | Mizuho Securities | $26→$28 | buy | 55.64%Upside | Reiterated | 10/08/26 | ||
| Richard Newitter | Truist Financial | $29 | buy | 61.20%Upside | Initiated | 09/24/26 | ||
| Kallum Titchmarsh | Morgan Stanley | $21 | buy | 16.73%Upside | Assigned | 09/18/26 | ||
| Steven Lichtman | William Blair | ― | buy | ― | Reiterated | 09/14/26 | ||
| Larry Biegelsen | Wells Fargo | $22→$26 | buy | 44.52%Upside | Reiterated | 09/08/26 | ||
| Patrick Wood | UBS | $25→$28 | buy | 55.64%Upside | Reiterated | 09/02/26 | ||
| Daniel Markowitz CFA | Evercore ISI | $20→$27 | buy | 50.08%Upside | Reiterated | 09/02/26 | ||
| Pito Chickering | Deutsche Bank | $20→$25 | buy | 38.97%Upside | Assigned | 09/02/26 | ||
| Travis Steed | Bank of America Securities | $24→$28 | buy | 55.64%Upside | Reiterated | 09/01/26 | ||
| Matthew O'Brien | Piper Sandler | $16 | hold | -11.06%Downside | Reiterated | 06/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Christopher PasqualeBarclays | HoldReiterated$22→$20 | 11/13/26 | 11.17%Upside | ||
| Joanne WuenschCiti | BuyReiterated$26 | 10/21/26 | 44.52%Upside | ||
| Issie KirbyRothschild & Co Redburn | BuyInitiated$30 | 10/13/26 | 66.76%Upside | ||
| Michael ToomeyJefferies | HoldInitiated$22 | 10/12/26 | 22.29%Upside | ||
| Marie ThibaultBTIG | BuyReiterated$28 | 10/09/26 | 55.64%Upside | ||
| Anthony PetroneMizuho Securities | BuyReiterated$26→$28 | 10/08/26 | 55.64%Upside | ||
| Richard NewitterTruist Financial | BuyInitiated$29 | 09/24/26 | 61.20%Upside | ||
| Kallum TitchmarshMorgan Stanley | BuyAssigned$21 | 09/18/26 | 16.73%Upside | ||
| Steven LichtmanWilliam Blair | BuyReiterated | 09/14/26 | ― | ||
| Larry BiegelsenWells Fargo | BuyReiterated$22→$26 | 09/08/26 | 44.52%Upside | ||
| Patrick WoodUBS | BuyReiterated$25→$28 | 09/02/26 | 55.64%Upside | ||
| Daniel Markowitz CFAEvercore ISI | BuyReiterated$20→$27 | 09/02/26 | 50.08%Upside | ||
| Pito ChickeringDeutsche Bank | BuyAssigned$20→$25 | 09/02/26 | 38.97%Upside | ||
| Travis SteedBank of America Securities | BuyReiterated$24→$28 | 09/01/26 | 55.64%Upside | ||
| Matthew O'BrienPiper Sandler | HoldReiterated$16 | 06/04/26 | -11.06%Downside |
Best Analysts Covering MiniMed Group, Inc.
Copying Joanne Wuensch's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +24.90% per trade.
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +15.83% per trade.
Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +15.83% per trade.
MMED Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 12 | 8 | 2 | 1 | 1 |
| Buy | 10 | 12 | 19 | 19 | 17 |
| Hold | 1 | 1 | 0 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 21 | 21 | 22 | 21 |
In the current month, MMED has received 18 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 26.00.
MMED Financial Forecast
MMED Earnings Forecast
Next quarter’s earnings estimate for MMED is $0.12 with a range of $0.06 to $0.23. The previous quarter’s EPS was $0.00. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
MMED Sales Forecast
Next quarter’s sales forecast for MMED is $825.16M with a range of $813.92M to $832.83M. The previous quarter’s sales results were $843.00M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

